Compound with MEK (Mitogen-activated and Extracellular signal-regulated Kinase) inhibiting function as well as preparation method and application of compound
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- PEKING UNIV
- Publication Date
- 2013-03-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The invention relates to a compound and a preparation method and application thereof, in particular to a compound with MEK inhibitory function and a preparation method and application thereof. Such compounds have obvious anti-tumor and anti-viral effects, so they may be used in the treatment of tumors and viral diseases. Background technique
[0002] Mitogen-activated protein kinase (MAPK) is an important protein kinase discovered in the mid-1980s and is an important core signaling pathway in cells. The MAPK pathway is mainly divided into four types of sub-families: extracellular signal-regulated kinase (ERK) pathway, JNK pathway, p38 pathway and ERK5 pathway. The ERK pathway is an important family of the MAPK pathway. It is mainly composed of three core protein kinases Raf, MEK (Mitogen-activated and Extracellular signal-regulated Kinase) and ERK, which are activated sequentially to form an accurate and efficient signal network pathway. Play an important...